Arrhythmogenic cardiomyopathy (AC) is an inherited disorder characterized by lethal
arrhythmias and a risk to sudden cardiac death. A hallmark feature of AC is the progressive …

Acute myocardial infarction (AMI) is one of the leading causes of death worldwide. Despite
recent advances in clinical management, reoccurence of heart failure after AMI remains …

Methylglyoxal (MG) is a highly reactive dicarbonyl and the main precursor of advanced
glycation end‐products (AGEs). After myocardial infarction (MI), MG‐derived AGEs …

Intrapericardial administration has been proposed as an alternative delivery route of
pharmacological agents via the bilaminar sac of pericardium surrounding the heart. To date …

Cardiovascular diseases (CVD) are the leading cause of death worldwide. Growth factor
therapy has emerged as novel therapeutic strategy under investigation for CVD. In this …

Delivery of therapeutic‐laden biomaterials to the epicardial surface of the heart presents a
promising method of treating a variety of diseased conditions by offering targeted, localized …

Purpose Due to low therapeutic efficacy and severe adverse reaction of systemic
administration for coronary heart disease (CHD) therapy, we designed a novel local target …

冠状动脉支架内再狭窄成为药物涂层球囊(DCB) 的主要适应证后, DCB 越来越多地作为其一线
治疗方式. 此外, 更多的临床证据支持DCB 在原位病变中的应用, 尤其是小血管病变 …

Cardiovascular disease is one of the leading causes of death in the developed world.
Ischemic heart disease and acute myocardial infarction can cause progressive left …

Ischemic cardiomyopathies, such as myocardial infarction (MI), are a leading cause of heart
failure in both men and women throughout the world. Despite timely intervention post-MI, the …